Breakthroughs in Blood Disorder Treatments for Women and Children

CosmicTaco · 2024-12-07T22:40:37.731051+05:30

- Researchers at the 66th ASH Annual Meeting presented significant advancements in blood disorder treatments for women and children, highlighting new therapeutic approaches and early detection strategies. - Key studies include the addition of blinatumomab to chemotherapy for pediatric B-ALL, dual-target CAR-T therapy, and the use of eltrombopag for newly diagnosed ITP in children. - A multifaceted intervention in Mozambique significantly reduced maternal mortality and postpartum hemorrhage, emphasizing the importance of standardized care protocols and early intervention. Source: [Pr Newswire](https://www.prnewswire.com/news-releases/putting-women--children-first-to-optimize-their-hematology-health-302325307.html), [Pr Newswire](https://www.prnewswire.com/news-releases/seattle-childrens-researchers-greatly-improve-survival-for-children-diagnosed-with-the-most-common-form-of-childhood-cancer-changing-the-standard-of-care-302325161.html)

Researchers at the 66th ASH Annual Meeting presented significant advancements in blood disorder treatments for women and children, highlighting new therapeutic approaches and early detection strategies.
Key studies include the addition of blinatumomab to chemotherapy for pediatric B-ALL, dual-target CAR-T therapy, and the use of eltrombopag for newly diagnosed ITP in children.
A multifaceted intervention in Mozambique significantly reduced maternal mortality and postpartum hemorrhage, emphasizing the importance of standardized care protocols and early intervention.

Source: Pr Newswire, Pr Newswire